NCT04511351 Radiotherapy Combined With GDP With or Without Chidamide in Stage I/II Extranodal Nasal NK/T-cell Lymphoma Status UNKNOWN Phase NA
NCT04504526 Value of Chemokine Receptor CXCR4 Imaging for Diagnosis and Prognostic Evaluation in Lymphoproliferative Diseases Status RECRUITING Phase EARLY_PHASE1
NCT04497701 Evaluate the Efficacy and Safety of the Prophylactic Use of PEG-rhG-CSF in Children With Hematological Malignancies Status UNKNOWN Phase NA
NCT04496011 Effect of the Cycloergometer in Patients Undergoing Hematopoietic Stem Cell Transplantation Status UNKNOWN Phase NA
NCT04478318 Comparison of Imaging Characteristics of uEXPLORER and Conventional PET/CT in Patients With Lung Cancer, Lymphoma, and Melanoma Status ACTIVE_NOT_RECRUITING Phase NA
NCT04472286 Healthy Bones, Healthy Life: Habitual Physical Activity on Bone & Metabolic Health in Pediatric Cancer Survivors Status COMPLETED Phase N/A
NCT04465760 Xisomab 3G3 for the Prevention of Catheter-Associated Thrombosis in Patients With Cancer Receiving Chemotherapy Status TERMINATED Phase PHASE2
NCT04464798 A Dose Finding and Safety Study of CC-220, Alone and in Combination With an Anti-CD20 Monoclonal Antibody (mAb) in Subjects With Relapsed or Refractory Lymphomas Status TERMINATED Phase PHASE1
NCT04460508 Mecapegfilgrastim(PEG-G-CSF) for Prophylaxis of Chemotherapy-induced Neutropenia in Patients With Lymphoma Status UNKNOWN Phase PHASE2
NCT04434937 Open-Label Study of Parsaclisib, in Japanese Participants With Relapsed or Refractory Follicular Lymphoma (CITADEL-213) Status COMPLETED Phase PHASE2
NCT04407741 Phase Ⅰ/Ⅱ Study of SHR2554 in Combination With SHR1701 in Patients With Advanced Solid Tumors and B-cell Lymphomas Status RECRUITING Phase PHASE1/PHASE2
NCT04406285 Effects of Periodized and Autoregulated Resistance Training in Haematological Cancer Patients During the Treatent. Status UNKNOWN Phase NA
NCT04386512 Clinical Epidemiology and Characteristics Of Covid-19 Cases Occurred In A Lymphoma Setting In The First Epidemic Phase (LymphoCov1) Status COMPLETED Phase N/A
NCT04349306 Evaluate the Efficacy and Safety of Rasburicase (Fasturtec®) in the Prevention and Treatment of Hyperuricemia in Pediatric Patients With Non-Hodgkin's Lymphoma and Acute Leukemia Status COMPLETED Phase PHASE4
NCT04342117 Observational Trial of Real-World Treatment Utilization and Effectiveness of PI3K-inhibitors in CLL/SLL and FL Status TERMINATED Phase N/A
NCT04320420 Feasibility of an Adapted Physical Activity Program for Patients Treated With an Autograft (APA²) Status UNKNOWN Phase NA